81 related articles for article (PubMed ID: 33250741)
1. RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients?
Zanaglio C; Bernardi S; Gandolfi L; Farina M; Re F; Polverelli N; Zollner T; Turra A; Morello E; Malagola M; Russo D
Case Rep Oncol; 2020; 13(3):1263-1269. PubMed ID: 33250741
[TBL] [Abstract][Full Text] [Related]
2. The Environmental Microbiology Minimum Information (EMMI) Guidelines: qPCR and dPCR Quality and Reporting for Environmental Microbiology.
Borchardt MA; Boehm AB; Salit M; Spencer SK; Wigginton KR; Noble RT
Environ Sci Technol; 2021 Aug; 55(15):10210-10223. PubMed ID: 34286966
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.
Hays A; Wissel M; Colletti K; Soon R; Azadeh M; Smith J; Doddareddy R; Chalfant M; Adamowicz W; Ramaswamy SS; Dholakiya SL; Guelman S; Gullick B; Durham J; Rennier K; Nagilla P; Muruganandham A; Diaz M; Tierney C; John K; Valentine J; Lockman T; Liu HY; Moritz B; Ouedraogo JP; Piche MS; Smet M; Murphy J; Koenig K; Zybura A; Vyhlidal C; Mercier J; Jani N; Kubista M; Birch D; Morse K; Johansson O
AAPS J; 2024 Feb; 26(1):24. PubMed ID: 38316745
[TBL] [Abstract][Full Text] [Related]
4. Digital PCR: a tool in clostridial mutant selection and detection.
Dierick E; Callens C; De Spiegelaere W; Ducatelle R; Van Immerseel F; Goossens E
Appl Microbiol Biotechnol; 2023 Nov; 107(22):6973-6983. PubMed ID: 37704769
[TBL] [Abstract][Full Text] [Related]
5. Addition to "The Environmental Microbiology Minimum Information (EMMI) Guidelines: qPCR and dPCR Quality and Reporting for Environmental Microbiology".
Borchardt MA; Boehm AB; Salit M; Spencer SK; Wigginton KR; Noble RT
Environ Sci Technol; 2023 Aug; 57(34):12931. PubMed ID: 37594384
[No Abstract] [Full Text] [Related]
6. Correspondence on "The Environmental Microbiology Minimum Information (EMMI) Guidelines: qPCR and dPCR Quality and Reporting for Environmental Microbiology".
Crank K; Papp K; Barber C; Wang P; Bivins A; Gerrity D
Environ Sci Technol; 2023 Dec; 57(48):20448-20449. PubMed ID: 37948750
[No Abstract] [Full Text] [Related]
7. Rebuttal to Correspondence on "The Environmental Microbiology Minimum Information (EMMI) Guidelines: qPCR and dPCR Quality and Reporting for Environmental Microbiology".
Borchardt MA; Boehm AB; Salit M; Spencer SK; Wigginton KR; Noble RT
Environ Sci Technol; 2023 Dec; 57(48):20450-20451. PubMed ID: 37932026
[No Abstract] [Full Text] [Related]
8. Digital PCR for
Kockerols CCB; Valk PJM; Levin MD; Pallisgaard N; Cornelissen JJ; Westerweel PE
Hemasphere; 2020 Dec; 4(6):e496. PubMed ID: 33283168
[TBL] [Abstract][Full Text] [Related]
9. How to manage CML patients with comorbidities.
Cortes J
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):237-242. PubMed ID: 33275749
[TBL] [Abstract][Full Text] [Related]
10. First-generation vs second-generation tyrosine kinase inhibitors: which is best at diagnosis of chronic phase chronic myeloid leukemia?
Oehler VG
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):228-236. PubMed ID: 33275713
[TBL] [Abstract][Full Text] [Related]
11. Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
Soverini S; Bernardi S; Galimberti S
J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33261150
[TBL] [Abstract][Full Text] [Related]
12. Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?
Bernardi S; Vallati M; Gatta R
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473210
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules.
Bernardi S; Mulas O; Mutti S; Costa A; Russo D; La Nasa G
Front Oncol; 2023; 13():1239042. PubMed ID: 38260856
[TBL] [Abstract][Full Text] [Related]
14. Effect of
Park H; Kim HJ; Sohn SK; Baik Y; Kim D; Lee SY; Kong JH; Kim H; Shin DY; Ahn JS; Park J; Park S; Kim I
Ther Adv Hematol; 2023; 14():20406207231205637. PubMed ID: 37929079
[TBL] [Abstract][Full Text] [Related]
15. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).
Abruzzese E; Bocchia M; Trawinska MM; Raspadori D; Bondanini F; Sicuranza A; Pacelli P; Re F; Cavalleri A; Farina M; Malagola M; Russo D; De Fabritiis P; Bernardi S
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627140
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsies and minimal residual disease in lymphoid malignancies.
Bou Zerdan M; Kassab J; Saba L; Haroun E; Bou Zerdan M; Allam S; Nasr L; Macaron W; Mammadli M; Abou Moussa S; Chaulagain CP
Front Oncol; 2023; 13():1173701. PubMed ID: 37228488
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of tyrosine kinase inhibitors based on
Kim Y; Kim S; Lee JM; Ahn A; Yoo JW; Lee JW; Cho B; Chung NG; Kim Y; Kim M
Front Pediatr; 2022; 10():928136. PubMed ID: 35967571
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
